ORAMED PHARMACEUTICALS INC. reports

Company location: New York, NY
Fiscal year end: 31 December

ORAMED PHARMACEUTICALS INC. has filed 932 SEC EDGAR filings since 29 Nov 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 201-225 of 773 matching filings.

Per page

25

Current page

9

4

4 filing

Filing date: 10 May 2022
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 May 2022
Reporting date: 02 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 04 Apr 2022
Reporting date: 01 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 04 Apr 2022
Reporting date: 30 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-QT File 001-35813

TRANSITION REPORT

Filing date: 30 Mar 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 22 Mar 2022
Reporting date: 21 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 28 Feb 2022
Reporting date: 28 Feb 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 22 Feb 2022
Reporting date: 17 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

4/A filing

Filing date: 15 Feb 2022
Reporting date: 11 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 14 Feb 2022
Reporting date: 11 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 12 Jan 2022
Reporting date: 12 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 11 Jan 2022
Reporting date: 09 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 11 Jan 2022
Reporting date: 09 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

4/A filing

Filing date: 11 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-35813

QUARTERLY REPORT

Filing date: 11 Jan 2022
Reporting date: 30 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 30 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .